Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Providers Support FDA Quest For Public Drug Manufacturing Quality Ratings

Executive Summary

Agency agrees with those who prescribe and buy drugs on need to incentivize quality. Except providers want it yesterday.

You may also be interested in...



Cleveland Clinic Drug Quality Dashboard Helps Guide Product Choices

After realizing some generics don’t work, academic medical center screens quality by manufacturer. Other providers protest: It’s not our job.

Cleveland Clinic Drug Quality Dashboard Helps Guide Product Choices

After realizing some generics don’t work, academic medical center screens quality by manufacturer. Other providers protest: It’s not our job.

Civica Interested In Retired Or Withdrawn ANDAs

As a part of its strategy to develop its own ANDAs for essential medications, Civica has expressed interest in taking over existing ANDAs that are being retired or withdrawn by other generics manufacturers.

Related Content

Topics

UsernamePublicRestriction

Register

PS141692

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel